Literature DB >> 23123917

In Vitro assessment of the utility of stearyl triphenyl phosphonium modified liposomes in overcoming the resistance of ovarian carcinoma Ovcar-3 cells to paclitaxel.

Melani A Solomon1, Anee A Shah, Gerard G M D'Souza.   

Abstract

Paclitaxel loaded in liposomes modified with stearyl triphenyl phosphonium (STPP) showed improved mitochondrial colocalization and cytotoxicity in a paclitaxel resistant cell line. The improvement in cytotoxicity was not solely due to the increased accumulation of paclitaxel in mitochondria but also due to the specific toxicity of STPP towards the resistant cell line. Mechanistic studies revealed that the cytotoxicity of STPP was associated with a decrease in mitochondrial membrane potential and other hallmarks related to caspase-independent cell death (CICD). This specific toxicity of STPP towards the paclitaxel resistant cell line was also maintained in three-dimensional in vitro spheroid cultures.
Copyright © 2012 © Elsevier B.V. and Mitochondria Research Society. All rights reserved. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Liposomes; Mitochondria; Spheroids; Stearyl triphenyl phosphonium; Sub-cellular delivery

Mesh:

Substances:

Year:  2012        PMID: 23123917     DOI: 10.1016/j.mito.2012.10.013

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  9 in total

Review 1.  Targeted nanoparticles in mitochondrial medicine.

Authors:  Rakesh K Pathak; Nagesh Kolishetti; Shanta Dhar
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-10-27

Review 2.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

Review 3.  Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents.

Authors:  Mofei Huang; Charles R Myers; Yian Wang; Ming You
Journal:  Cancer Prev Res (Phila)       Date:  2020-12-10

4.  From broad-spectrum biocides to quorum sensing disruptors and mussel repellents: antifouling profile of alkyl triphenylphosphonium salts.

Authors:  Alberto J Martín-Rodríguez; Jose M F Babarro; Fernando Lahoz; Marta Sansón; Víctor S Martín; Manuel Norte; José J Fernández
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

5.  ROS-Responsive Mitochondria-Targeting Blended Nanoparticles: Chemo- and Photodynamic Synergistic Therapy for Lung Cancer with On-Demand Drug Release upon Irradiation with a Single Light Source.

Authors:  Caixia Yue; Yuming Yang; Chunlei Zhang; Gabriel Alfranca; Shangli Cheng; Lijun Ma; Yanlei Liu; Xiao Zhi; Jian Ni; Weihua Jiang; Jie Song; Jesús M de la Fuente; Daxiang Cui
Journal:  Theranostics       Date:  2016-10-01       Impact factor: 11.556

6.  Enhanced Subcellular Trafficking of Resveratrol Using Mitochondriotropic Liposomes in Cancer Cells.

Authors:  Ji Hee Kang; Young Tag Ko
Journal:  Pharmaceutics       Date:  2019-08-20       Impact factor: 6.321

7.  Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance.

Authors:  Xue Han; Ruijuan Su; Xiuqing Huang; Yingli Wang; Xiao Kuang; Shuang Zhou; Hongzhuo Liu
Journal:  Asian J Pharm Sci       Date:  2018-09-18       Impact factor: 6.598

Review 8.  Mitochondria-targeting particles.

Authors:  Amaraporn Wongrakpanich; Sean M Geary; Mei-ling A Joiner; Mark E Anderson; Aliasger K Salem
Journal:  Nanomedicine (Lond)       Date:  2014-11       Impact factor: 6.096

Review 9.  Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents.

Authors:  Josephine S Modica-Napolitano; Volkmar Weissig
Journal:  Int J Mol Sci       Date:  2015-07-29       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.